We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,083

EU Court Confirms European Commission’s Decision on Pay-for-Delay Agreements
  • McDermott Will & Emery
  • Denmark, European Union
  • October 20 2016

On 8 September 2016, the General Court of the European Union upheld the European Commission’s decision in which the antitrust regulator imposed fines

Lundbeck provides more questions than answers on pay-for-delay settlements
  • Baker & McKenzie
  • European Union
  • October 20 2016

Two years after the US Supreme Court's ruling in Actavis, the EU General Court has opined for the first time on the legality of reverse payment

Antitrust Competition and Economic Regulation quarterly newsletter - Autumn 2016
  • Hogan Lovells
  • China, European Union, Germany, Global, OECD, United Kingdom, USA
  • October 19 2016

On 20 September 2016, the Second Circuit Court of Appeals in the United States overturned a federal district court judgment in a class action

EU General Court upholds European Commission’s strict approach to “Pay-for-delay” agreements
  • Dechert LLP
  • European Union, USA
  • October 7 2016

In a series of rulings dated 8 September 2016, the EU General Court (General Court) upheld the European Commission (Commission) decision of 19 June

ONPOINT Lettre d'information - Droit de la concurrence
  • Dechert LLP
  • European Union
  • October 7 2016

Le Tribunal de l'Union européenne valide dans l’affaire Lundbeck l’approche stricte adoptée par la Commission européenne en

General Court upholds Commission's decision that reverse payment settlements constitute a 'by object' infringement
  • Stibbe
  • European Union
  • October 3 2016

On 8 September 2016, the General Court ("GC") dismissed in their entirety the appeals brought by Lundbeck and the generic companies Alpharma, Merck

General Court of the EU Confirms Fines Imposed on Lundbeck and Generic Drug Manufacturers for Entering into Patent Settlements
  • McDermott Will & Emery
  • European Union
  • September 22 2016

On 8 September 2016, the General Court of the EU (GCEU) handed down five judgments upholding a decision by the Commission of 19 June 2013 imposing

How the impending Brexit impacts the legal framework of doing business with the UK- the German perspective
  • Heuking Kühn Lüer Wojtek
  • European Union, Germany, United Kingdom
  • September 20 2016

In a referendum, held in the United Kingdom on June 23, 2016, a majority of voters decided in favor of the United Kingdom of Great Britain and

EU & Competition Law Review 14 September 2016
  • Roschier
  • European Union, Finland
  • September 14 2016

On 8 September 2016, the General Court ("GC") gave six judgments dismissing appeals by Lundbeck, a Danish pharmaceutical company, and several generic

"Pay for Delay" Agreements infringe EU Competition Law: European General Court
  • Bird & Bird
  • European Union
  • September 13 2016

The European General Court has issued a judgment confirming that "pay for delay" agreements in the pharmaceuticals sector constitute serious